InspireMD (NSPR) Liabilities and Shareholders Equity (2010 - 2025)

InspireMD's Liabilities and Shareholders Equity history runs 16 years deep, the most recent figure standing at $69.4 million for Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity rose 48.28% year-over-year to $69.4 million in Q4 2025; TTM through Dec 2025 was $219.9 million, a 12.78% increase from a year earlier, with the FY2025 full-year figure at $69.4 million, up 48.28% from the prior year.
• Liabilities and Shareholders Equity slipped to $69.4 million in Q4 2025 per NSPR's latest filing, from $78.5 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $78.5 million in Q3 2025 and bottomed at $19.9 million in Q1 2023.
• The 5-year median for Liabilities and Shareholders Equity is $44.5 million (2021), against an average of $44.2 million.
• Across the five-year window, Liabilities and Shareholders Equity soared 558.56% in 2021 and slumped 43.36% in 2023, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $39.7 million in 2021, then sank by 37.92% to $24.7 million in 2022, then surged by 93.25% to $47.6 million in 2023, then decreased by 1.75% to $46.8 million in 2024, then jumped by 48.28% to $69.4 million in 2025.
• Per Business Quant, the three latest NSPR Liabilities and Shareholders Equity figures stand at $69.4 million (Q4 2025), $78.5 million (Q3 2025), and $33.3 million (Q2 2025).